Kristin A Shadman
Affiliation: University of Wisconsin
- A review of palivizumab and emerging therapies for respiratory syncytial virusKristin A Shadman
University of Wisconsin School of Medicine and Public Health, Department of Pediatrics, 600 Highland Avenue, Box 4108, Madison, WI 53792, USA
Expert Opin Biol Ther 11:1455-67. 2011..Palivizumab, the only approved specific monoclonal antibody for RSV is used prophylactically to reduce morbidity in a select population of high-risk children...